Moderna
MRNA
#1416
Rank
S$16.63 B
Marketcap
$43.02
Share price
2.03%
Change (1 day)
-71.16%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2024 (TTM): -S$4.86 Billion

According to Moderna 's latest financial reports the company's current earnings are S$3.19 Billion. , an increase over its 2023 earnings that were of -S$5.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2024

Annual earnings

Year Earnings Change
2024 -S$4.8 Billion-8.22%
2023 -S$5.23 Billion-140.65%
2022 S$12.86 B-27.81%
2021 S$17.81 B-1911.15%
2020 -S$0.99 Billion44.7%
2019 -S$0.68 Billion28.63%
2018 -S$0.53 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$55.42 Million-98.85%๐Ÿ‡บ๐Ÿ‡ธ USA
S$28.40 B-691.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$55.94 Million-98.83%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.32 Billion-93.43%๐Ÿ‡บ๐Ÿ‡ธ USA
S$18.27 B-480.69%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-S$0.81 Billion-83.25%๐Ÿ‡บ๐Ÿ‡ธ USA
S$23.36 B-586.80%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.16 Billion-96.72%๐Ÿ‡บ๐Ÿ‡ธ USA